Results 61 to 70 of about 25,264,236 (332)

The role of skills from worklessness to sustainable employment with progression [PDF]

open access: yes, 2011
This study is shaped by the recognition that while there has been a great deal of policy development around the transition from unemployment and inactivity to employment over the last decade, policy has not been sufficiently informed about how best to ...
Bickerstaffe, Tim   +6 more
core   +1 more source

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

Evidence for laryngeal aspiration in Greek? Part I: The 'recent' evidence [PDF]

open access: yes, 2011
Since de Saussure, H. Pedersen and Kurylowicz the Sanskrit (and Indo-Iranian) voiceless aspirates are considered to be the result from the combination of a plain voiceless plosive and a laryngeal (*h(2) according to most scholars), and, consequently, the
De Decker, Filip
core   +2 more sources

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Validation of electronic bills of exchange in Iranian law by looking at American law in the light of UNCITRAL

open access: yesحقوق فناوریهای نوین, 2023
lectronic bill of lading has a special place in commercial law today. On the one hand, in parallel with the observance of business principles, including the principle of the speed of business affairs, its electronification is also inevitable and requires
Ali Keshavarz   +2 more
doaj  

‘Peer Disagreement’ and Evidence of Evidence [PDF]

open access: yes, 2018
What the rational thing to do in the face of disagreement by an epistemic peer is has been much discussed recently. Those who think that a peer’s disagreement is itself evidence against one’s belief, as many do, are committed to a special form of ...
Biro, John, Lampert, Fabio
core  

Realism And Empirical Evidence [PDF]

open access: yes, 1997
We define realism using a slightly modified version of the EPR criterion of reality. This version is strong enough to show that relativity is incomplete.
Schmelzer, Ilja
core   +3 more sources

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy